| Home > Publications Database > Molecular Mechanisms Mediating the Transfer of Disease-Associated Proteins and Effects on Neuronal Activity. > print |
| 001 | 165354 | ||
| 005 | 20240301164619.0 | ||
| 024 | 7 | _ | |a 10.3233/JPD-223516 |2 doi |
| 024 | 7 | _ | |a pmid:36278361 |2 pmid |
| 024 | 7 | _ | |a 1877-7171 |2 ISSN |
| 024 | 7 | _ | |a 1877-718X |2 ISSN |
| 024 | 7 | _ | |a altmetric:137623223 |2 altmetric |
| 037 | _ | _ | |a DZNE-2022-01631 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Brás, Inês C |b 0 |
| 245 | _ | _ | |a Molecular Mechanisms Mediating the Transfer of Disease-Associated Proteins and Effects on Neuronal Activity. |
| 260 | _ | _ | |a Amsterdam |c 2022 |b IOS Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1709307967_5354 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Various cellular pathways have been implicated in the transfer of disease-related proteins between cells, contributing to disease progression and neurodegeneration. However, the overall effects of protein transfer are still unclear.Here, we performed a systematic comparison of basic molecular mechanisms involved in the release of alpha-synuclein, Tau, and huntingtin, and evaluated functional effects upon internalization by receiving cells.Evaluation of protein release to the extracellular space in a free form and in extracellular vesicles using an optimized ultracentrifugation protocol. The extracellular effects of the proteins and extracellular vesicles in primary neuronal cultures were assessed using multi-channel electrophysiological recordings combined with a customized spike sorting framework.We demonstrate cells differentially release free-forms of each protein to the extracellular space. Importantly, neuronal activity is distinctly modulated upon protein internalization in primary cortical cultures. In addition, these disease-related proteins also occur in extracellular vesicles, and are enriched in ectosomes. Internalization of ectosomes and exosomes by primary microglial or astrocytic cells elicits the production of pro-inflammatory cytokines, and modifies spontaneous electrical activity in neurons.Overall, our study demonstrates that released proteins can have detrimental effects for surrounding cells, and suggests protein release pathways may be exploited as therapeutic targets in different neurodegenerative diseases. |
| 536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Alpha-synuclein |2 Other |
| 650 | _ | 7 | |a Tau |2 Other |
| 650 | _ | 7 | |a extracellular vesicles |2 Other |
| 650 | _ | 7 | |a huntingtin |2 Other |
| 650 | _ | 7 | |a neuronal function |2 Other |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Parkinson Disease: metabolism |2 MeSH |
| 650 | _ | 2 | |a Neurons: metabolism |2 MeSH |
| 650 | _ | 2 | |a Exosomes: metabolism |2 MeSH |
| 650 | _ | 2 | |a Protein Transport |2 MeSH |
| 700 | 1 | _ | |a Khani, Mohammad H |b 1 |
| 700 | 1 | _ | |a Vasili, Eftychia |b 2 |
| 700 | 1 | _ | |a Möbius, Wiebke |b 3 |
| 700 | 1 | _ | |a Riedel, Dietmar |b 4 |
| 700 | 1 | _ | |a Parfentev, Iwan |b 5 |
| 700 | 1 | _ | |a Gerhardt, Ellen |b 6 |
| 700 | 1 | _ | |a Fahlbusch, Christiane |b 7 |
| 700 | 1 | _ | |a Urlaub, Henning |b 8 |
| 700 | 1 | _ | |a Zweckstetter, Markus |0 P:(DE-2719)2810591 |b 9 |u dzne |
| 700 | 1 | _ | |a Gollisch, Tim |b 10 |
| 700 | 1 | _ | |a Outeiro, Tiago F |0 P:(DE-2719)2814138 |b 11 |e Last author |u dzne |
| 773 | _ | _ | |a 10.3233/JPD-223516 |g p. 1 - 26 |0 PERI:(DE-600)2599550-9 |n 8 |p 2397 - 2422 |t Journal of Parkinson's Disease |v 12 |y 2022 |x 1877-7171 |
| 856 | 4 | _ | |u https://content.iospress.com/articles/journal-of-parkinsons-disease/jpd223516 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/165354/files/DZNE-2022-01631_Restricted.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/165354/files/DZNE-2022-01631_Restricted.pdf?subformat=pdfa |x pdfa |
| 909 | C | O | |p VDB |o oai:pub.dzne.de:165354 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)2810591 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 11 |6 P:(DE-2719)2814138 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 0 |
| 914 | 1 | _ | |y 2022 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-01-28 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-01-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-25 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-25 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J PARKINSON DIS : 2021 |d 2022-11-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-25 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-25 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b J PARKINSON DIS : 2021 |d 2022-11-25 |
| 920 | 1 | _ | |0 I:(DE-2719)1410002 |k AG Fischer |l Epigenetics and Systems Medicine in Neurodegenerative Diseases |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1410001 |k AG Zweckstetter |l Translational Structural Biology |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1410002 |
| 980 | _ | _ | |a I:(DE-2719)1410001 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|